CAS
MDT icon

CTC Alternative Strategies’s Medtronic MDT Stock Holding History

CTC Alternative Strategies’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,363
Closed -$303K – 72
2024
Q3 		$303K Sell
3,363
-2,637
-44% -$222K 0.38% 34
2024
Q2 		$472K Buy
+6,000
New +$492K 0.2% 118
2023
Q3 		– Sell
-2,900
Closed -$255K – 146
2023
Q2 		$255K Buy
+2,900
New +$250K 0.32% 95
2013
Q3 		– Sell
-6,200
Closed -$319K – 151
2013
Q2 		$319K Buy
+6,200
New +$306K 0.09% 113

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CTC Alternative Strategies's MDT Position: Q4 2024 in Review

CTC Alternative Strategies sold out of Medtronic (MDT) in Q4 2024, closing a stake of 3,363 shares — an estimated $303K sold.

CTC Alternative Strategies first reported a position in MDT in Q2 2013 and held it in 4 quarters. The position peaked at $472K in Q2 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • CTC Alternative Strategies reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • CTC Alternative Strategies sold 3,363 Medtronic shares in Q4 2024, an estimated $303K.
  • CTC Alternative Strategies first reported a position in Medtronic in Q2 2013 and held it in 4 quarters.
  • CTC Alternative Strategies's Medtronic position peaked at $472K in Q2 2024.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on CTC Alternative Strategies's 13F filing for Q4 2024, filed 19 Feb 2025.